Baxter NovumIQ Syringe INFUSION SYSTEM , REF 40800BAXUS — FDA record Z-1423-2025

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Mar 3, 2025. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Baxter NovumIQ Syringe INFUSION SYSTEM , REF 40800BAXUS
Reason
Baxter Healthcare Corporation is issuing an Urgent Medical Device Recall for the Novum IQ syringe pumps listed below due to an incorrectly installed gasket. A gasket failure could lead to potential fluid ingress due to cleaning, or as a result of an IV fluid spill.
Classification
Class II
Recalling firm
Baxter Healthcare Corporation
Quantity
149 units
Agency-reported status
Ongoing
Source record identifier
Z-1423-2025

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityUDI/DI 05413765852428, Serial Numbers: 02A220600103, 02A221100387, 02A240800201, 02A230300471, 02A240800161, 02A220600112, 02A230100474, 02A240800343, 02A230400357, 02A240800175, 02A220700259, 02A230200471, 02A240800710, 02A230600165, 02A240800223, 02A220700176, 02A230200487, 02A240900081, 02A230600175, 02A240800513, 02A220700349, 02A230300030, 02A240900133, 02A230600176, 02A240800577, 02A220700268, 02A230300117, 02A240900265, 02A230600255, 02A240900261, 02A220700081, 02A230300125, 02A240900277, 02A230600256, 02A240900421, 02A220700140, 02A230300132, 02A240900285, 02A230600618, 02A240900742, 02A220700351, 02A230300146, 02A240900287, 02A230700137, 02A240900746, 02A220700409, 02A230300275, 02A240900282, 02A241000576, 02A240901067, 02A220700368, 02A230300287, 02A240900373, 02A220700166, 02A240901181, 02A220700428, 02A230300309, 02A240900407, 02A221000108, 02A240901422, 02A220700450, 02A230300350, 02A240900422, 02A221000346, 02A240901428, 02A220700454, 02A230300389, 02A240900423, 02A221000349, 02A240901430, 02A220700458, 02A230300477, 02A240900443, 02A221100154, 02A241000027, 02A220800010, 02A230300520, 02A240900427, 02A221100208, 02A241000051, 02A220800060, 02A230300547, 02A240900502, 02A221100201, 02A241000251, 02A220800201, 02A230400035, 02A240900681, 02A230200462, 02A241000254, 02A220800407, 02A230400145, 02A240900677, 02A230200495, 02A241000366, 02A221000109, 02A230600421, 02A240900749, 02A230300091, 02A241000479, 02A221000233, 02A230600549, 02A240900811, 02A230300342, 02A241000862, 02A221000240, 02A230600792, 02A240900981, 02A230300367, 02A241001284, 02A221000360, 02A230600820, 02A240901095, 02A230300417, 02A241001392, 02A221000099, 02A230600894, 02A240901196, 02A230300533, 02A241001413, 02A221100056, 02A230600908, 02A240901243, 02A230400030, 02A241001478, 02A221100116, 02A230700053, 02A241000498, 02A230600496, 02A241001496, 02A221100244, 02A230700043, 02A241000939, 02A240800026, 02A241100021, 02A221100260, 02A240600468, 02A241000957, 02A240800050, 02A241100037, 02A221100294, 02A240800006, 02A230300466, 02A240800069, 02A241100047, 02A221100346, 02A240800007, 02A230300467, 02A240800142.

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

US Nationwide distribution in the states of AR, CA, FL, IA, IN, LA, MO, MT, NC, NY, OH, OR, PA, TN, TX, VA, WA, WI, WV.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Apr 2, 2025
Recall initiation date
Mar 3, 2025
Center classification date
Mar 21, 2025

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records